Cases-Cunillera S, van Loo KMJ, Pitsch J, Quatraccioni A, et al. Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss. Neuro Oncol 2022;24:741-754.
PMID: 34865163